About 17 results found for searched term "Urokinase" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21537 | Urokinase | Animal Modeling |
| Urokinase is a proteolytic enzyme. It has potent antithrombotic activity and has a local vasodilatory effect. It can be used to construct animal models of deep vein thrombosis. | ||
| M45059 | Recombinant Human uPA (Mammalian, C-6His) | Recombinant Proteins |
| Urokinase-Type Plasminogen Activator; U-Plasminogen Activator | ||
| Recombinant Human Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. | ||
| M3366 | Amiloride hydrochloride dihydrate | Sodium Channel |
| MK-870 hydrochloride dihydrate | ||
| Amiloride Hydrochloride Dihydrate (MK-870 Hydrochloride Dihydrate) is an inhibitor of epithelial sodium channel (ENaC) and urokinase-type plasminogen activator receptor (uTPA). Amiloride hydrochloride dihydrate is polycystin-2 (PC2; TRPP2) channel blocker. | ||
| M5288 | UK-371804 | Cathepsin |
| UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin). | ||
| M6342 | 4-Chlorophenylguanidine hydrochloride | Sodium Channel |
| 4-Chlorophenylguanidine hydrochloride is a urokinase inhibitor. | ||
| M8109 | UK-371,804 HCl | Others |
| UK-371,804 is a reversible, substrate-competitive, highly potent (Ki = 10 nM) and selective urokinase-type plasminogen activator (uPA) Inhibitor with excellent selectivity over tPA, plasmin, Factor IXa and Xa. | ||
| M9255 | UKI-1 | Serine/Threonine Protease |
| UKI-1 is a novel synthetic inhibitor of the urokinase-type plasminogen activator, which inhibits the invasive capacity of carcinoma cells with a Ki of 0.41 μM. | ||
| M9595 | Upamostat | Serine/Threonine Protease |
| WX-671; Mesupron | ||
| Upamostat (WX-671, umorestat) is a Urokinase-type Plasminogen Activator (uPA) inhibitor. | ||
| M10904 | Angstrom6 | Others |
| A6 Peptide | ||
| Angstrom6 (A6 Peptide) is an 8-amino acid peptide derived from single-stranded urokinase plasminogen activator (scuPA) that interferes with the uPA/uPAR cascade and eliminates downstream effects. Angstrom6 binds to CD44 to inhibit migration, invasion and metastasis of tumor cells and regulate CD44-mediated cell signaling. | ||
| M29454 | ZK824190 | Serine/Threonine Protease |
| ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively. | ||
| M29739 | ZK824190 hydrochloride | Serine/Threonine Protease |
| ZK824190 hydrochloride is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively. | ||
| M43210 | NOTA-AE105 | Others |
| NOTA-AE105 is an PET ligand of urokinase-type plasminogen activator receptor (uPAR), which can be radiolabeled by 64Cu and 68Ga. | ||
| M51018 | Boc-Glu-Lys-Lys-AMC | Others |
| Boc-Glu-Lys-Lys-AMC is a sensitive fluorogenic substrate for urokinase-activated plasmin. | ||
| M52516 | Ac-Gly-Lys-OMe | Serine/Threonine Protease |
| Ac-Gly-Lys-OMe is a substrate for urokinase. | ||
| M52520 | Z-Val-Gly-Arg-pNA | Serine/Threonine Protease |
| Z-Val-Gly-Arg-pNA is a chromogenic substrate for urokinase. | ||
| M52557 | GGACK | PAI-1 |
| GGACK (H-Glu-Gly-Arg-CMK) is an irreversible substrate-like serine protease urokinase-type plasminogen activator (uPA) inhibitor. | ||
| M52558 | Glutaryl-Gly-Arg-AMC | PAI-1 |
| Glutaryl-Gly-Arg-AMC is a peptide substrate of urokinase plasminogen activator (uPA). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
